Categories: All postsAnalysts

Medical Facilities Corp gets new $5.10 target from Industrial Alliance

Following the company’s second quarter results, Industrial Alliance Securities analyst Chelsea Stellick has raised her price target on Medical Facilities Corp (Medical Facilities Corp Stock Quote, Chart, News TSX:DR).

In a research update Thursday, Stellick maintained her “Speculative Buy” rating but upped her price target on DR from $4.50 to $5.10, a price that implied a return of 39 per cent at the time of publication.

The analyst summarized the quarter.

“MFC announced its quarterly results that beat consensus posting revenue of $88.8M (iA: $91M) and EBITDA of $24.6M (iA: $16.4M). EBITDA increased 19.9% YoY with EBITDA margins of 25.4% up from 17.3% last quarter,” the analyst noted. “Operations at MFC facilities were impacted in April by COVID-19 but began rebounding in May to return to prior year levels by June. With the St. Luke’s Surgery Centre ready to accept patients this month, we anticipate a stronger H2/20 in absence of a second wave of COVID-19 and anticipate the St. Luke’s facility will operate at full capacity by Q4. We have updated the model to include the results from Q2/20 resulting in a target increase from C$4.50 to C$5.10. We are maintaining our Speculative Buy rating.

Stellick thinks DR will post Adjusted EBITDA of $79.8-million on revenue of $383.8-million in fiscal 2020. The following year, she has modeled EBITDA of $77.7-million on a topline of $389.9-million.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: dr
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

2 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

2 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

3 days ago

Rogers is an undervalued stock, RBC says

With the integration of Shaw Communications underway, RBC analyst Drew McReynolds says Rogers Communications (Rogers Communications Stock Quote, Chart, News,… [Read More]

4 days ago

Tornado Global Hydrovacs is still a double, Beacon says

Following fourth quarter results he describes as "stronger than expected", Beacon Securities analyst Russell Stanley has raised his price target… [Read More]

4 days ago

Sell your Molson Coors stock, Citi says

Ahead if its first quarter results, Citi analyst Filippo Falorni says there is not much to like about Molson Coors… [Read More]

5 days ago